EcoDrugPlus

Ensembl ID : ENSMOCG00000022731
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSMOCG00000002794
Gene Symbol: -
Cross references: -
70 Possible Orthologues:

Ensembl ID : ENSMOCG00000001977
Gene Symbol: -
Cross references: -
70 Possible Orthologues:

Ensembl ID : ENSMOCG00000000055
Gene Symbol: -
Cross references: -
399 Possible Orthologues:

Ensembl ID : ENSMOCG00000000112
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSMOCG00000001628
Gene Symbol: -
Cross references: -
88 Possible Orthologues:

Ensembl ID : ENSMOCG00000008827
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSMOCG00000002742
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSMOCG00000002691
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSMOCG00000002249
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSMOCG00000000128
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSMOCG00000017900
Gene Symbol: -
Cross references: -
141 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).